Table 3.
Occurrence of secondary endpoints
| Secondary Endpoints, n (%) | eMVO + (n = 74) | eMVO - (n = 33) | p-value |
|---|---|---|---|
| Death |
3 (4.1) |
1 (3.0) |
.797 |
| CV-death |
2 (2.7) |
1 (3.0) |
.678 |
| Re-infarction |
9 (12.3) |
2 (6.1) |
.327 |
| Re-CAG |
23 (31.5) |
8 (24.2) |
.446 |
| Ischemic symptoms |
18 (24.7) |
2 (6.1) |
.023* |
| Stroke |
1 (1.4) |
0 (0.0) |
.496 |
| Atrial fibrillation |
6 (8.2) |
0 (0.0) |
.090 |
| Congestive heart failure |
9 (12.3) |
0 (0.0) |
.035* |
| Hospitalisation |
44 (60.3) |
13 (39.4) |
.046* |
| CV-hospitalisation |
34 (46.6) |
9 (28.1) |
.077 |
|
SUM |
49 (66.2) |
14 (42.4) |
.021* |
| * Chi-square p < 0.05 |
Comparison of eMVO + and eMVO- patients according to the occurrence of the secondary endpoints (*p < 0.05). eMVO: early microvascular obstruction, CV: cardiovascular, CAG: coronary angiography.